BETA

IPO registrations (S-1, F-1) · Registrants

GLOBEIMMUNE INC

SEC CIK
1245104 · filings on EDGAR ↗
Registration
Form S-1, first filed 2012-07-02, last 2014-06-30; 2 initial registrations, 9 amendments
Outcome
Final prospectus filed 2014-07-02; declared effective 2014-07-01; withdrawal requested 2013-10-30
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1450 INFINITE DRIVE, Louisville, CO 80027
EIN
84-1353925
EDGAR entity type
operating
Insiders and CEO pay
GLOBEIMMUNE INC on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2014-07-02, an initial public offering)
Shares sold
1,500,000
Gross proceeds
$15,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol GBIM
Lead underwriters
Aegis Capital

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2012-07-02S-1S-1 (registration)GLOBEIMMUNE INC0001193125-12-292349 ↗
2012-07-17S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-12-304855 ↗
2012-08-16S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-12-359199 ↗
2012-09-05S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-12-379579 ↗
2013-10-30RWRW (withdrawal request)GLOBEIMMUNE INC0001193125-13-417656 ↗
2014-03-17S-1S-1 (registration)GLOBEIMMUNE INC0001193125-14-100625 ↗
2014-04-29S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-163974 ↗
2014-05-21S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-208179 ↗
2014-06-04S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-225457 ↗
2014-06-16S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-237920 ↗
2014-06-24S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-245861 ↗
2014-06-30S-1/AS-1/A (amendment)GLOBEIMMUNE INC0001193125-14-253833 ↗
2014-07-01EFFECTEFFECT (declared effective)GLOBEIMMUNE INC9999999995-14-001999 ↗
2014-07-02424B4424B4 (final prospectus)GLOBEIMMUNE INC0001193125-14-259325 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-06-30S-1/Aregistration statement$15.001,000,000$15,000,000Nasdaq GBIM1primary document; price sentence, shares headline, proceeds computed, cover names 1document ↗
2014-07-02424B4final prospectus$10.001,500,000$15,000,000Nasdaq GBIM1primary document; price sentence, shares headline, proceeds table, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
CAVANAUGH JAMES HOther; TenPercentOwner52014–2016
CELGENE CORP /DE/TenPercentOwner22014
Celgene International IncTenPercentOwner22014
Christoffersen Kirk AOfficerVP, Corporate Development42014–2015
Dekker C. JeffreyOfficerVP, Finance, Treas & Sec22014–2015
FREYTAG J WILLIAMDirector22014–2015
HealthCare Partners VII, L.P.Other; TenPercentOwner52014–2016
HEALTHCARE VENTURES VII LPOther; TenPercentOwner52014–2016
LAWLOR AUGUSTINEDirector; DirectorOther; Director,TenPercentOwner132014–2016
LITTLECHILD JOHN WOther; TenPercentOwner52014–2016
Mirabelli ChristopherOther; TenPercentOwner52014–2016
MITCHELL DANIEL JDirector142014–2016
Morgenthaler Management Partners VII, LLCTenPercentOwner22014
MORGENTHALER PARTNERS VII LPTenPercentOwner22014
RODELL TIMOTHY C JRDirector,OfficerCEO & Pres42014–2015
Safer PenninaDirector22014
Torres S. EdwardDirector52014–2016person page Fuzzy
WERNER HAROLD ROther; TenPercentOwner52014–2016

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-03-23GLOBEIMMUNE INCPharmaceuticals$2,100,000$2,100,00011
2014-03-12GLOBEIMMUNE INCPharmaceuticals$391,730$391,73011
2014-02-13GLOBEIMMUNE INCPharmaceuticals$7,500,000$7,500,0001102

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationGLOBEIMMUNE, INC.COState business registriesname and state
Plan sponsorGLOBEIMMUNE, INC.CAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientGLOBEIMMUNE, INC.COFederal spending (USAspending)name and state
Form D issuerGLOBEIMMUNE INCCOForm D private offeringsCIK (EXACT)
Patent assigneeGlobeImmune, Inc.COPatents (USPTO)name and state
SEC filerGLOBEIMMUNE INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerGlobeimmune, Inc.COTrademarks (USPTO)name and state
Form 5500 plan sponsorGLOBEIMMUNE, INC.EIN (EXACT)
Person pageS Edward TorresPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CO first:

More with this interest.

In other datasets, the same topic (Health) in CO:

Interests: Pharmaceutical Preparations · Health